-

Pegasus Development Major Upcoming IPO in 2021

FRANKFURT, Germany--(BUSINESS WIRE)--Pegasus Development, Inc. is pleased to announce that the first important step for the planned IPO / Listing in 2021 has been taken. The application with the SEC / EDGAR - Securities and Exchange Commission in the USA has been approved and the registration in the IPO register has taken place. Planned IPO date is June 2021, the main venues are Frankfurt and New York stock exchanges. With multiple rounds of financing, investors will have the opportunity to invest in a growing company and receive equity or a portion of the company in return.

The default-free bond repayments and the high sales figures of the past years have enormously strengthened the confidence of the investors in Pegasus Development and give the internationally positioned company the decisive psychological advantage for the IPO.

Above all, the growth in operating business despite COVID-19 is the decisive signal effect for all shareholders. Important here are the dialogues with major American investors who would like to accompany this lucrative IPO. At an early stage it can be seen here that good business is also being weathered in the environment and many parties would like to participate on this IPO.

Pre-IPO shares with right of first refusal are usually traded exclusively among financial institutions and major investors and are not accessible to private investors. However, Pegasus Development has announced for its existing investors that a contingent of forehanded shares will be made available to thank them for their trust over the last 20 years and give them the opportunity to participate in the game of the big ones without having to provide millions of dollars.

All in all, we can look forward to a strong performance and are eagerly awaiting further events.

Language: English
Company: Pegasus Development GmbH
Friedrich-Ebert-Anlage 36
60325 Frankfurt am Main
Germany
Internet: www.pegasusdevelopment.de

 

Contacts

Jimmie Martikainen
Tel.: +1 929 277 1459
Fax: +1 929 262 0468
Homepage: www. pegasusdevelopment-inc.com
info@pegasusdevelopment-inc.com

Pegasus Development GmbH


Release Versions

Contacts

Jimmie Martikainen
Tel.: +1 929 277 1459
Fax: +1 929 262 0468
Homepage: www. pegasusdevelopment-inc.com
info@pegasusdevelopment-inc.com

More News From Pegasus Development GmbH

Pegasus Development AG: Green Light for Multiple Production Sites Worldwide

CHUR, Switzerland--(BUSINESS WIRE)--Announcement: Expansion of the Pegastril-Nuevo production facility Under the leadership of board member Roberto Spano, the management of Pegasus Development AG has decided to further expand Pegastril-Nuevo production facilities. New production facilities will be set up at several locations across the world and the site in Turkey is being expanded. These investments will also create new jobs. The takeover and expansion of the following production facilities ar...

Pegasus Development AG: Pegasus Present Its New Brand Pegastril - Nuevo

CHUR, Switzerland--(BUSINESS WIRE)--The coronavirus pandemic harbours the potential for enormous growth in specific industries. To that end, however, it's important to identify which markets will be dominant in the future. One of the key growth sectors is the production and distribution of disinfectants and associated technologies. Regardless of whether a cure for, or vaccine against, COVID-19 is developed, protection against viruses and bacteria has become incredibly important across the globe...

Pegasus Development AG: Partnership With UK-Based Chemical Company Nuevo

CHUR, Switzerland--(BUSINESS WIRE)--Restaurants and coffee shops are closed. The doors of shopping centres and shops remain closed. Most of the production facilities are at standstill or have gone into short-time working. In short: the economy has ground to a halt. However, there are a number of industries that are benefiting strongly from the corona crisis. The current high demand for disinfectants plays into the cards of chemical, pharmaceutical and biotech companies. It is precisely these co...
Back to Newsroom